Leishmania and Leishmaniasis
Leishmania-related illnesses remain among the world’s deadliest neglected tropical diseases, affecting approximately 12 million people in 88 countries. The mortality rate is substantial, contributing to nearly two million disability-adjusted life years. As more is understood about this parasite and...
| Κύριος συγγραφέας: | |
|---|---|
| Συγγραφή απο Οργανισμό/Αρχή: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Σειρά: | SpringerBriefs in Immunology,
3 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Historical background of Leishmania and leishmaniasis
- Risk factors and definition of the problem
- Types of leishmaniasis
- Global status of visceral leishmaniasis
- Status of visceral leishmaniasis in India
- Morphology and Life cycle of Leishmania donovani
- Vectors and transmission of the disease
- Clinical symptoms of visceral leishmaniasis
- Control strategies of the disease
- Leishmania/HIV co-infections
- Host Immune response to Leishmania infection
- Cross-immunity between different Leishmania species
- Adoptive transfer of immunity
- Cutaneous leishmaniasis
- Mucocutaneous Leishmaniasis
- Visceral Leishmaniasis
- Post Kala-azar dermal Leishmaniasis
- Drugs against leishmaniasis
- Antimonials and Leishmaniasis
- SAG treatment, failure and resistance in Leishmania
- Vaccines against Leishmaniasis
- Strategy in practice for vaccine development against Leishmanisis.
